JOURNEY II XR
Device
Smith+Nephew, Inc.
Total Payments
$955,375
Transactions
545
Doctors
107
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $38,623 | 31 | 8 |
| 2023 | $172,211 | 51 | 12 |
| 2022 | $130,058 | 92 | 25 |
| 2021 | $226,364 | 182 | 61 |
| 2020 | $388,118 | 189 | 31 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $623,652 | 229 | 65.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $148,111 | 49 | 15.5% |
| Royalty or License | $104,874 | 94 | 11.0% |
| Consulting Fee | $40,450 | 9 | 4.2% |
| Travel and Lodging | $30,991 | 76 | 3.2% |
| Food and Beverage | $4,749 | 87 | 0.5% |
| Space rental or facility fees (teaching hospital only) | $2,547 | 1 | 0.3% |
Payments by Type
Research
$623,652
229 transactions
General
$331,722
316 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Prospective Multicenter, Post-Market Clinical Follow-Up Study to Evaluate the Safety and Effectiveness of the Journey II XR Total Knee System | Smith+Nephew, Inc. | $448,824 | 0 |
| Safety and Performance of Journey II XR Total Knee System A Retrospective Multicenter Study | Smith+Nephew, Inc. | $128,960 | 0 |
| A Prospective Multicenter,Post-Market Clinical Follow-Up Study to Evaluate the Safety and Effectiveness of the Journey II XR Total Knee System | Smith+Nephew, Inc. | $26,016 | 0 |
| A Retrospective-Prospective Study of REDAPT Revision Femoral System Modular Stem and/or Acetabular components Previously Implanted | Smith+Nephew, Inc. | $11,455 | 0 |
| Safety and performance of Journey II XR Total Knee System A Retrospective Multicenter Study | Smith+Nephew, Inc. | $6,482 | 0 |
| A Prospective, Multicenter, Post-Market Clinical Follow-Up Study to Evaluate the Safety and Effectiveness of the Journey II XR Total Knee System | Smith+Nephew, Inc. | $1,915 | 0 |
Top Doctors Receiving Payments for JOURNEY II XR
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Phoenix, AZ | $628,690 | 231 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Reno, NV | $78,476 | 38 |
| , MD | Orthopaedic Surgery | Wilmington, NC | $25,258 | 8 |
| , M.D | Specialist | Arlington, VA | $20,301 | 20 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Somerset, NJ | $20,230 | 20 |
| , MD | Orthopaedic Surgery | Port Huron, MI | $15,621 | 14 |
| , DO | Orthopaedic Surgery | Battle Creek, MI | $15,322 | 7 |
| , MD | Orthopaedic Surgery | Salisbury, NC | $15,099 | 12 |
| , MD | Orthopaedic Surgery | Aurora, IL | $14,347 | 7 |
| , M.D., M.SC | General Acute Care Hospital | Orange, CA | $12,701 | 7 |
| , M.D | Pediatric Orthopaedic Surgery | La Jolla, CA | $11,500 | 1 |
| , D.O | Adult Reconstructive Orthopaedic Surgery | Kenosha, WI | $10,799 | 8 |
| , M.D | Orthopaedic Surgery | Lihue, HI | $9,475 | 5 |
| , M.D | Orthopaedic Surgery | Atlanta, GA | $9,186 | 2 |
| , MD | Orthopaedic Surgery | Staten Island, NY | $8,120 | 20 |
| , M.D | Orthopaedic Trauma | Huntington, WV | $5,700 | 2 |
| , M.D | Orthopaedic Surgery | Morton Grove, IL | $4,875 | 5 |
| , M.D | Orthopaedic Surgery | Jonesboro, AR | $4,574 | 6 |
| , M.D | Anesthesiology | Naperville, IL | $4,500 | 3 |
| , M.D | Orthopaedic Surgery | New York, NY | $3,738 | 1 |
| , DO | Orthopaedic Surgery | Brighton, MI | $3,575 | 1 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Lexington, KY | $3,422 | 4 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Arlington, VA | $3,048 | 6 |
| , M.D | Orthopaedic Surgery | Draper, UT | $1,713 | 4 |
| , M.D | Orthopaedic Surgery | Van Nuys, CA | $1,689 | 2 |
Ad
Manufacturing Companies
- Smith+Nephew, Inc. $955,375
Product Information
- Type Device
- Total Payments $955,375
- Total Doctors 107
- Transactions 545
About JOURNEY II XR
JOURNEY II XR is a device associated with $955,375 in payments to 107 healthcare providers, recorded across 545 transactions in the CMS Open Payments database. The primary manufacturer is Smith+Nephew, Inc..
Payment data is available from 2020 to 2024. In 2024, $38,623 was paid across 31 transactions to 8 doctors.
The most common payment nature for JOURNEY II XR is "Unspecified" ($623,652, 65.3% of total).
JOURNEY II XR is associated with 6 research studies, including "A Prospective Multicenter, Post-Market Clinical Follow-Up Study to Evaluate the Safety and Effectiveness of the Journey II XR Total Knee System" ($448,824).